Evidence map›Paper›PMID 34831521›Full record

ArticleInternational journal of environmental research and public health2021

Occurrence of Pharmaceuticals and Endocrine Disrupting Compounds in Brazilian Water and the Risks They May Represent to Human Health.

Sérgio Francisco de Aquino, Emanuel Manfred Freire Brandt, Sue Ellen Costa Bottrel, Fernanda Bento Rosa Gomes, Silvana de Queiroz Silva

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sérgio Francisco de AquinoChemistry Department, Federal University of Ouro Preto (UFOP), Ouro Preto 35400-000, MG, Brazil.ORCID 0000-0001-6058-3218
Emanuel Manfred Freire BrandtEnvironmental and Sanitary Engineering Department, Federal University of Juiz de Fora (UFJF), Juiz de Fora 36036-900, MG, Brazil.
Sue Ellen Costa BottrelEnvironmental and Sanitary Engineering Department, Federal University of Juiz de Fora (UFJF), Juiz de Fora 36036-900, MG, Brazil.ORCID 0000-0001-9755-4074
Fernanda Bento Rosa GomesCivil Engineering Graduate Programme, Federal University of Juiz de Fora (UFJF), Juiz de Fora 36036-900, MG, Brazil.
Silvana de Queiroz SilvaBiological Sciences Department, Federal University of Ouro Preto (UFOP), Ouro Preto 35400-000, MG, Brazil.ORCID 0000-0002-0077-4669
Universidade Federal de Juiz de Fora · BRUniversidade Federal de Ouro Preto · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The risks of pharmaceuticals and endocrine disrupting compounds (P&EDC) to the environment and human health are a current topic of interest. Hundreds of P&EDC may reach the environment, hence, there is a need to rank the level of concern of human exposure to these compounds. Thus, this work aimed at setting a priority list of P&EDC in Brazil, by studying their occurrence in raw and drinking water, calculating health guideline values (GV), and estimating the risks of population exposure to water intake. Data on the Brazilian pharmaceutical market as well as published data of the monitoring of Brazilian natural and drinking water have been collected by means of an exhaustive literature review. Furthermore, many foreign data were also collected to enable a comparison of the values found in Brazilian studies. A list of 55 P&EDC that have the potential to be found in Brazilian water is proposed, and for 41 of these a risk assessment was performed by estimating their margin of exposure (ME), by considering their occurrence in drinking water, and guideline values estimated from reported acceptable daily intake (ADI) data. For seven compounds the risk was deemed high (three estrogens and four anti-inflammatories), whereas for another seven compounds, it was regarded as an 'alert' situation. Although such risk analysis is conservative, since it has been calculated based on the highest reported P&EDC concentration in drinking water, it highlights the need to enhance their monitoring in Brazil to strengthen the database and support decision makers. An analysis of the occurrence of antimicrobial resistance agents (antibiotics, resistant bacteria, and resistance genes) in surface waters was also carried out and confirmed that such agents are present in water sources throughout Brazil, which deserves the attention of policy makers and health agents to prevent dissemination of antimicrobial resistance through water use.

Indexed as

Drinking WaterPharmaceutical PreparationsWater Pollutants, ChemicalBrazilEnvironmental MonitoringHumansDrinking WaterPharmaceutical PreparationsWater Pollutants, Chemicalantibioticsantimicrobial resistancecontaminants of emerging concerndrinking waterhormonesquantitative chemical risk assessmentresistance genesresistant bacteria

Identifiers

PMID34831521
PMCPMC8620687
OpenAlexW3213210482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.